Sponsor or institution
Clinical trials and research at Remix Therapeutics
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Remix Therapeutics that are recruiting, at sites in 2 countries (most in France (2), United States (2)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Investigating REM-422 for patients with higher risk MDS or relapsed AML
This study is testing a new oral medication called REM-422 to see if it can help people with higher risk myelodysplastic syndromes or relapsed acute myeloid leukemia feel better and fight their cancer.
-
Treatment of advanced Adenoid Cystic Carcinoma with REM-422
This study is testing a new oral medication called REM-422 to see if it can safely shrink tumors in people with advanced Adenoid Cystic Carcinoma that keeps coming back or has spread.
Quick answers
How many clinical trials run by Remix Therapeutics are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.